New COVID drugs face delays as trials grow more difficult - Nature.com

Fewer people are eligible for the massive studies needed to test treatments for severe COVID-19.

The antiviral tablet Paxlovid sharply reduces risk of hospitalization and death from COVID-19.Credit: Chris Sweda/Chicago Tribune/Tribune News Service via Getty After two years of breakneck research… [+6258 chars]

full article...